Mary Koestler

1.5k total citations · 1 hit paper
12 papers, 410 citations indexed

About

Mary Koestler is a scholar working on Psychiatry and Mental health, Surgery and Molecular Biology. According to data from OpenAlex, Mary Koestler has authored 12 papers receiving a total of 410 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Psychiatry and Mental health, 3 papers in Surgery and 3 papers in Molecular Biology. Recurrent topics in Mary Koestler's work include Alzheimer's disease research and treatments (3 papers), Epilepsy research and treatment (2 papers) and Dementia and Cognitive Impairment Research (2 papers). Mary Koestler is often cited by papers focused on Alzheimer's disease research and treatments (3 papers), Epilepsy research and treatment (2 papers) and Dementia and Cognitive Impairment Research (2 papers). Mary Koestler collaborates with scholars based in United States, Netherlands and United Kingdom. Mary Koestler's co-authors include Jerome Schofferman, James B. Reynolds, Noel Goldthwaite, Paul Slosar, Adam L. Boxer, Alexander J. Beagle, Katherine L. Possin, Kamalini G. Ranasinghe, Wenbo Zhang and Michael J. Howell and has published in prestigious journals such as Spine, Obstetrics and Gynecology and JAMA Neurology.

In The Last Decade

Mary Koestler

11 papers receiving 397 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Effect of Levetiracetam on Cognition in Patients With Alzheimer Disease With and Without Epileptiform Activity

2021 163 citations Keith Vossel, Kamalini G. Ranasinghe et al. JAMA Neurology profile →

Peers

Countries citing papers authored by Mary Koestler

Since Specialization

Citations

This map shows the geographic impact of Mary Koestler's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mary Koestler with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mary Koestler more than expected).

Fields of papers citing papers by Mary Koestler

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mary Koestler. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mary Koestler. The network helps show where Mary Koestler may publish in the future.

Co-authorship network of co-authors of Mary Koestler

This figure shows the co-authorship network connecting the top 25 collaborators of Mary Koestler. A scholar is included among the top collaborators of Mary Koestler based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mary Koestler. Mary Koestler is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

12 of 12 papers shown

#	Work	Indexed citations
1	Introduction to Veri‐T: A Phase 1 Randomized, Double‐Blind, Placebo‐Controlled, Multicenter Trial of Verdiperstat in Patients with svPPA Due to FTLD‐TDP 2022 ·Alzheimer s & Dementia ·Peter A. Ljubenkov, Adam M. Staffaroni, Julio C. Rojas, Lawren VandeVrede, Mary Koestler, (unknown), (unknown), (unknown), Hilary W. Heuer, Ian Grant, David J. Irwin, Bradley F. Boeve, Howard J. Rosen, David S. Knopman, Robert Bowser, Murray Grossman, Irfan Qureshi, Adam L. Boxer	1
2	Effect of Levetiracetam on Cognition in Patients With Alzheimer Disease With and Without Epileptiform Activity breakdown → 2021 ·JAMA Neurology ·Keith Vossel, Kamalini G. Ranasinghe, Alexander J. Beagle, (unknown), (unknown), (unknown), Danielle Mizuiri, Susanne Honma, (unknown), Mary Koestler, Wenbo Zhang, Lennart Mucke, Michael J. Howell, Katherine L. Possin, Joel H. Kramer, Adam L. Boxer, Bruce L. Miller, Srikantan S. Nagarajan, Heidi E. Kirsch	163
3	A phase 1b, randomized, double‐blind, placebo‐controlled, parallel cohort safety, tolerability, pharmacokinetics, pharmacodynamics and preliminary efficacy study of intravenously infused BIIB092 in patients with four different primary tauopathy syndromes 2021 ·Alzheimer s & Dementia ·Peter A. Ljubenkov, Lawren VandeVrede, Julio C. Rojas, Richard Tsai, Mary Koestler, Danielle Graham, Tien Dam, Adam L. Boxer	1
4	Symptomatic amyloid‐related imaging abnormalities in an APOE ε4/ε4 patient treated with aducanumab 2020 ·Alzheimer s & Dementia Diagnosis Assessment & Disease Monitoring ·Lawren VandeVrede, Daniel M. Gibbs, Mary Koestler, Renaud La Joie, Peter A. Ljubenkov, Karine Provost, David N. Soleimani‐Meigooni, Amelia Strom, Elena Tsoy, Gil D. Rabinovici, Adam L. Boxer	52
5	Open‐Label Phase 1 Futility Studies of Salsalate and Young Plasma in Progressive Supranuclear Palsy 2020 ·Movement Disorders Clinical Practice ·Lawren VandeVrede, Marian L. Dale, Scott Fields, (unknown), Emma Hare, Hilary W. Heuer, (unknown), Mary Koestler, Peter A. Ljubenkov, (unknown), (unknown), Jennifer C. Richards, Julio C. Rojas, Elisabeth H. Thijssen, Christine M. Walsh, Ping Wang, Amy Wolf, Joseph F. Quinn, Richard Tsai, Adam L. Boxer	43
6	Primary chronic traumatic encephalopathy in an older patient with late-onset AD phenotype 2015 ·Neurology Clinical Practice ·Carolyn Fredericks, Mary Koestler, William W. Seeley, Bruce L. Miller, Adam L. Boxer, Lea T. Grinberg	4
7	P2‐403: A randomized, multicenter, placebo controlled trial of memantine for behavioral variant FTD and semantic variant PPA 2012 ·Alzheimer s & Dementia ·Adam L. Boxer, David S. Knopman, Daniel Kaufer, Murray Grossman, Chiadi U. Onyike, Neill R. Graff‐Radford, Mario F. Mendez, Diana Kerwin, Alan J. Lerner, Chuang‐Kuo Wu, Mary Koestler, (unknown), (unknown), Robert I. Nicholson, Bruce Miller	0
8	Web-based Touch-Screen Computer Assessment of Chronic Low Back Pain 2005 ·CIN Computers Informatics Nursing ·Mary Koestler, (unknown), Jerome Schofferman, (unknown)	9
9	Upper Cervical Anterior Diskectomy and Fusion Improves Discogenic Cervical Headaches 2002 ·Spine ·Jerome Schofferman, Kim J. Garges, Noel Goldthwaite, Mary Koestler, (unknown)	37
10	A Prospective Randomized Comparison of 270° Fusions to 360° Fusions (Circumferential Fusions) 2001 ·Spine ·Jerome Schofferman, Paul Slosar, James B. Reynolds, Noel Goldthwaite, Mary Koestler	61
11	The axial cage 2001 ·The Spine Journal ·Paul Slosar, James B. Reynolds, Mary Koestler	23
12	Influence of Human Immunodeficiency Virus Infection on Pelvic Inflammatory Disease 2000 ·Obstetrics and Gynecology ·Kathleen L. Irwin, Anne C. Moorman, Mary Jo O’Sullivan, Rhoda Sperling, Mary Koestler, (unknown), R J Rice, Michael Brodman, Salih Yasin, (unknown), (unknown), David A. Schwartz, Robert H. Byers	16

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact